ResMed (NYSE:RMD), a leading developer, manufacturer, and distributor of
sleep and respiratory medical equipment, today introduced its new
cutting-edge sleep apnoea therapy platform called the S9 Series in
Europe. The S9 Series combines a sleek design with superior
functionality and more comfort. Combined climate control and
humidification delivers unsurpassed comfort to the patient by
controlling both the temperature and humidity that the patient breathes.
The S9 Series is expected to help more sleep apnoea patients adhere to
the treatment, but also help sleep professionals make more informed
decisions.
“With patients across the world in mind, we are thrilled to introduce a
true revolution in positive airway pressure therapy”
The most effective treatment for sleep apnoea is Continuous Positive
Airway Pressure (CPAP) therapy. In this non-invasive treatment, air is
pressurised by a small device and delivered to the airway of the patient
through a mask that fits on/over the nose, or nose and mouth. The
pressurised air keeps the upper airway open and helps the person to get
a restful night without interruptions caused by apnoeas.
“With patients across the world in mind, we are thrilled to introduce a
true revolution in positive airway pressure therapy,” said Michael
Farrell, SVP of the Global Sleep Business Unit at ResMed. “ResMed is
convinced that the S9 Series will contribute to improved patient
comfort, compliance and outcomes; in the long run, this should lead to
more healthcare savings. Air is delivered quietly and comfortably at the
precise temperature and humidity that the sleeping patient, provider,
and physician have set; this will make a significant difference in
patient comfort. In addition to the advanced features, clinical
algorithms, connectivity options, the S9 Series design fits right into
any patient’s home. This next generation CPAP and APAP series no longer
has the look and feel of hospital equipment – S9 Series is true homecare
at its best.”
Sleep apnoea is one of the more common, and yet highly undiagnosed,
sleep disorders. The condition causes the sufferer to stop breathing
throughout the night. There are three types of sleep apnoea;
obstructive, mixed and central. Obstructive sleep apnoea (OSA) is the
most common and is marked by the collapse or obstruction of the airway
during sleep. The new S9 system treats OSA while also detecting central
sleep apnoea and reporting a central apnea index for follow-up by
providers and physicians.
A new study published in Science Translational Medicine, shows
that it is very hard to catch up on lost sleep, and that the fatigue
that follows interrupted sleep presents safety risks in traffic and at
the workplace. A person with untreated sleep apnoea does not have the
opportunity to catch up on lost sleep since the condition is a daily
occurrence.
In addition to road and workplace accidents, the condition is
responsible for contributing to extreme sleepiness, nodding off during
the day, inability to perform optionally at work, elevated levels of
blood pressure, heart disease, diabetes, episodes of stroke, and
depression. While many people perceive snoring as a common harmless
problem, it can be a clear sign of this serious condition.
SOURCE ResMed